BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 25641194)

  • 1. The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.
    Zhuo H; Tang J; Lin Z; Jiang R; Zhang X; Ji J; Wang P; Sun B
    Mol Carcinog; 2016 Feb; 55(2):209-19. PubMed ID: 25641194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer.
    Zamani M; Sadeghizadeh M; Behmanesh M; Najafi F
    Phytomedicine; 2015 Sep; 22(10):961-7. PubMed ID: 26321746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
    Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
    Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel mTOR inhibitor Torin-2 induces autophagy and downregulates the expression of UHRF1 to suppress hepatocarcinoma cell growth.
    Wang C; Wang X; Su Z; Fei H; Liu X; Pan Q
    Oncol Rep; 2015 Oct; 34(4):1708-16. PubMed ID: 26239364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UHRF1 is an oncogene that promotes DNA hypomethylation.
    Cancer Discov; 2014 Apr; 4(4):OF9. PubMed ID: 24706678
    [No Abstract]   [Full Text] [Related]  

  • 6. Aberrant Expression of CCAT1 Regulated by c-Myc Predicts the Prognosis of Hepatocellular Carcinoma.
    Zhu HQ; Zhou X; Chang H; Li HG; Liu FF; Ma CQ; Lu J
    Asian Pac J Cancer Prev; 2015; 16(13):5181-5. PubMed ID: 26225650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
    Jin L; He Y; Tang S; Huang S
    J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
    Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
    PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 increases the stability of G9a and ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 messenger RNA through recruiting eukaryotic translation initiation factor 4A3, transcriptionally inhibiting PDZ and homeobox protein domain protein 1, and promotes the metastasis of hepatocellular carcinoma.
    Huang X; Zhou LZ; Feng WJ; Liu YQ; Chen M; Tang LY; Gan ZY; Zhang P
    J Gastroenterol Hepatol; 2024 Mar; 39(3):596-607. PubMed ID: 38059880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of
    Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
    Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma.
    Sun QM; Hu B; Fu PY; Tang WG; Zhang X; Zhan H; Sun C; He YF; Song K; Xiao YS; Sun J; Xu Y; Zhou J; Fan J
    Carcinogenesis; 2018 Dec; 39(12):1438-1446. PubMed ID: 30169594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between macrophage-derived PGE
    Zhang J; Zhang H; Ding X; Hu J; Li Y; Zhang J; Wang H; Qi S; Xie A; Shi J; Xiang M; Bin Y; Wang G; Wang L; Wang Z
    Theranostics; 2022; 12(8):3776-3793. PubMed ID: 35664070
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis.
    Li Y; Ren M; Zhao Y; Lu X; Wang M; Hu J; Lu G; He S
    Oncol Rep; 2017 Jun; 37(6):3527-3535. PubMed ID: 28440439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
    Liu Z; Chen JY; Zhong Y; Xie L; Li JS
    Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.
    Liu LX; Deng W; Zhou XT; Chen RP; Xiang MQ; Guo YT; Pu ZJ; Li R; Wang GF; Wu LF
    Int J Oncol; 2016 Jan; 48(1):421-9. PubMed ID: 26647875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.
    Lu KH; Li W; Liu XH; Sun M; Zhang ML; Wu WQ; Xie WP; Hou YY
    BMC Cancer; 2013 Oct; 13():461. PubMed ID: 24098911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664.
    He JH; Han ZP; Liu JM; Zhou JB; Zou MX; Lv YB; Li YG; Cao MR
    J Cell Biochem; 2017 Nov; 118(11):3713-3721. PubMed ID: 28374914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1.
    Yan J; Guo X; Xia J; Shan T; Gu C; Liang Z; Zhao W; Jin S
    Med Oncol; 2014 Mar; 31(3):879. PubMed ID: 24515776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma.
    Liang D; Xue H; Yu Y; Lv F; You W; Zhang B
    Int J Clin Exp Pathol; 2015; 8(8):9416-21. PubMed ID: 26464697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.